Showers Family Center for Childhood Cancer and Blood Disorders
Our specially trained and certified oncology staff treats a variety of pediatric cancers and offers a broad range of expertise in cancer and bleeding disorders. Studies have shown that the survival rates for infants, children, teens and young adults treated at a pediatric cancer center are greater than those at an adult hospital.
Learn more...Department: 330-543-8580
About Cancer and Blood Disorders
SPECIALIZED TEAMS FOR:
Hemostasis & Thrombosis
Sickle Cell
Bone Marrow Transplant
Pediatric Brain Tumor Program
National leader in improving quality and safety in Hematology-Oncology
In 2023, the Showers Family Center served patients from 40 counties in Ohio and 9 other states
542 Bleeding and clotting disorder patients
received care in 2023Make a donation to support the Showers Family Center for Childhood Cancer and Blood Disorders
Our team includes board-certified pediatric hematologists-oncologists, advanced practice nurses, physician assistants, certified pediatric oncology nurses, pharmacists, clinical research associates, child life specialists, social workers, psychologists and educators. We also work closely with other specialty departments as needed, including surgery, pathology, radiology, pain management, nutrition, adolescent medicine, physical therapy, palliative care and genetics.
On average, we care for 8 newly-diagnosed children with cancer each month. The most common types of cancer are leukemia, brain and central nervous system cancers.
We are also active in national clinical trials for childhood cancer and blood disorders and explore the causes and treatment of these diseases through our basic science research program.
As a member of Children’s Oncology Group (COG), we participate in the development of National Cancer Institute-approved treatment protocols and offer the most up-to-date cancer therapies. Our program is one of only about a dozen pediatric cancer programs in the country verified by the American College of Surgeons Commission on Cancer.
As a major teaching institution affiliated with Northeast Ohio Medical University, we also train future doctors who want to specialize in pediatric hematology-oncology through our accredited fellowship training program.
For children and teens with high-risk tumors or cancers that have been unresponsive to standard treatment options, we offer individualized therapies through our Shannon E. Wilkes Targeted Therapy Program. This form of medicine uses information about the genetic make-up of a patient's cancer to identify drugs or other treatments that block the growth and spread of cancer.
Targeted therapies are typically less harmful to normal cells than standard chemotherapy.
Cancer and Blood Disorders, Akron
Akron Children's Cancer and Blood DisordersMain Hospital Building
214 West Bowery Street
Akron, Ohio 44308
Fax: 330-543-3220
Map & directions
More about this location...
Appointments: 330-543-8580
Department: 330-543-8580
Cancer and Blood Disorders, Boardman
Akron Children's Center for Childhood Cancer and Blood Disorders, BoardmanLeonard J. Fisher Family Building
6505 Market Street, Building A
Boardman, Ohio 44512
Fax: 330-746-9523
Map & directions
More about this location...
Appointments: 330-746-9522
Department: 330-746-9522
Cancer and Blood Disorders, Millersburg
Akron Children's Cancer and Blood Disorders, Millersburg1261 Wooster Road
Suite 220
Millersburg, Ohio 44654
Map & directions
More about this location...
Appointments: 330-543-8580
Jeffrey Hord, MD
Director, Division of Hematology-Oncology; Pediatric Hematologist-Oncologist; LOPen Charities and Mawaka Family Chair in Pediatric Hematology/Oncology; Vice President, American Society of Pediatric Hematology/ Oncology 2023-2024
Hannah Elkus, MD, MS
Director, Quality Improvement, Co-Director Resident Quality Improvement Initiative; Pediatric Residency Core Faculty; Pediatric Hematologist-Oncologist
Nicole Kendel, MD
Director, Hemostasis and Thrombosis Center; Pediatric Hematologist-Oncologist
Sarah Rush, MD
Vice President, Informatics; Chief Medical Information Officer; Pediatric Neuro-Oncologist; Marci M. Matthews Endowed Chair in Telehealth
Megan Sampson, MD
Hematopoietic Stem Cell Transplantation Program Director; Pediatric Hematologist-Oncologist
Stephanie Savelli, MD
Director, Childhood Cancer Survivorship Program and Pediatric Hematology-Oncology Fellowship Program; Pediatric Hematologist-Oncologist
Erin Wright, MD
Director, Neuro-Oncology; Director, Shannon E. Wilkes Targeted Therapy Program; Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and Healing; Co-Director, Neurofibromatosis Clinic; Pediatric Neuro-Oncologist
Courtney Culbertson, MSN, APRN-CNP
Stem Cell Transplant Program Coordinator; Pediatric Nurse Practitioner; Co-Lead Hematology/Oncology Advance Practice Providers
Drew Westfall, MSN, APRN-CNP
Pediatric Nurse Practitioner; Co-Lead Hematology/Oncology Advance Practice Providers
1 of 9 Ped Cancer Programs
Recognized by the American College of Surgeons
1 of 150
Federally designated hemostasis & thrombosis centers in US
542 Patients
with bleeding & clotting disorders received care in 2023
1 of 6
Regional Sickle Cell Centers in Ohio
40 Counties and 9 Other States
Our patients come from 40 Ohio counties and 9 other states
Open Clinical Studies
Genetic Analysis Identifying Late Occurring Complications in Childhood Cancer Survivors (ALTE03N1)
For complete study information, please view the study on clinicaltrials.gov.
More about this studyEffects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure
For complete study information, please view the study on clinicaltrials.gov
More about this studyGuided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
For complete study information, please view the study on clinicaltrials.gov
More about this studyThe Project: Every Child Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
For complete information, please view the project on clinicaltrials.gov
More about this studyNeuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
For complete information, please visit the study on clinicaltrials.gov
More about this studySelumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
For complete details, please view the study on clinicaltrials.gov.
Study in conjunction with Cincinnati Children's Hospital.
More about this studyMaintenance Chemotherapy or Observation Following Induction Chemo and Radiation for Ependymoma
For complete information, please visit the study on clinicaltrials.gov
More about this studyBiomarkers in Tumor Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
For complete study details, please visit the study on clinicaltrials.gov.
More about this studySafety and efficacy of Ravulizumab for pediatric patients with thrombocytic microangiopathy following hematopoetic stem cell transplantation
View complete study details here.
More about this studyStudy to determine the safety and tolerability of SNDX-5613 in patients with relapsed/refractory leukemia
For complete information, please visit the study at clinicaltrials.gov.
More about this studyStudying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Please view the study at clinicaltrials.gov for complete details.
More about this studyA Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
For complete information, please visit the study at Clinicaltrials.gov.
More about this studyUnfortunately, we don't permit live plants on that unit due to infection control purposes.
Patients diagnosed with acute lymphocytic leukemia would be seen in our Cancer and Blood Disorders Center.
Akron Children’s offers many resources to support our cancer patients and their loved ones, not only while going through treatment but ongoing.
The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACS) has granted three-year accreditation to the cancer program at Akron Children's. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care.
Programs and Clinics
Conditions and Treatments:
ALL, AML, Astrocytoma, Bone Cancer, Bone and Soft Tissue Tumors, Brain and Spinal Cord Tumors, Cancer, Craniopharyngiomas, Ependymoma, Ewing Sarcoma, Germ Cell Tumors, Glioma, Hodgkin's Lymphoma, Kidney Tumors, Leukemia, Liver Tumors, Lymphoma, Medulloblastoma, Melanoma, Neuroblastoma, Neutropenia, Oligodendrogliomas, Osteosarcoma, Pineoblastomas, Retinoblastoma, Rhabdomyosarcoma, Thyroid Masses, Tumor, Aplastic Anemia, Bleeding Disorder, Blood Disorders, G6PD Deficiency, Hemophilia, Hereditary Hemorrhagic Telangiectasia, Idiopathic Thrombocytopenic Purpura, Iron-Deficiency Anemia, Severe Combined Immunodeficiency, Sickle Cell Anemia, Thalassemia, von Willebrand Disease